Church & Dwight (CHD) 2022 Barclays Global Consumer Staples Conference summary
Event summary combining transcript, slides, and related documents.
2022 Barclays Global Consumer Staples Conference summary
14 Nov, 2026Growth model and portfolio
Evergreen targets: domestic organic sales +2%, international +6%, SPD +5%; gross margin +25 bps, SG&A -25 bps, operating margin +50 bps and EPS growth +8%.
Ten-year average organic sales growth was 4.3% vs. a 3% target; average EPS growth was 10.6% vs. an 8% target.
Fifteen power brands represent more than 85% of sales and profits; the portfolio mix is 40% value and 60% premium.
Acquisition criteria prioritize #1 or #2 brands, higher growth and margins, asset-light businesses, use of existing capabilities and sustainable competitive advantage.
Category trends
Liquid laundry detergent category growth moderated in 2022, while Arm & Hammer consumption accelerated; the brand reached an all-time share high in August.
Consumers were shifting from premium to value liquid laundry detergent amid recessionary conditions.
Cat litter showed strong category growth and stronger Arm & Hammer consumption; vitamins and supplements slowed, with branded consumption trailing category trends.
Power oral care above $20 contracted as consumers pulled back or traded down; dry shampoo grew at double-digit rates, led by Batiste, and TheraBreath drove strong alcohol-free mouthwash growth.
Case fill rates improved from below 80% in Q1 toward 93%-95% by year-end, with improvement expected to support second-half category and share performance.
Hero acquisition and growth opportunity
Hero was the #2 acne care brand in the U.S. and the #1 acne patch brand, with 63% share of the patch category, over 5x its next closest competitor.
Hero household penetration was 4.4% vs. 23% for acne care overall; current ACV distribution was 8%, with a goal of 80%-90%.
The planned $630 million acquisition had trailing 12-month sales of $115 million and EBITDA of about $45 million, a 40% margin; expected to close in Q4, subject to customary conditions.
Hero was expected to add 3% to cash earnings and be neutral to adjusted 2023 EPS, including transition costs; leverage was projected at 2.0x exiting 2022 and below 2.0x in 2023.
Latest events from Church & Dwight
- Organic sales rose 5.1%, lifting FY guidance amid cost pressures.CHD
Q3 2026 - Sales and margins improved, but discretionary demand and brand-impairment risks persist.CHD
Q4 2023 - Power brands, innovation, and global expansion drive strong growth and raised 2026 targets.CHD
Barclays 19th Annual Global Consumer Conference - Organic sales up 5.8% and guidance raised on strong brand and innovation momentum.CHD
Q2 2026 - 4% organic growth, brand-led innovation and disciplined acquisitions drive expansion.CHD
Barclays 17th Annual Global Consumer Staples Conference - 2026 targets 3%-4% organic growth and 5%-8% EPS growth, led by Power Brands and innovation.CHD
Consumer Analyst Group of New York Conference (CAGNY) 2026 - Q3 sales and margin gains offset by a $357.1M vitamin impairment; outlook remains positive.CHD
Q3 2024 - Strong 2024 growth, innovation, and global expansion drive confidence in future performance.CHD
Consumer Analyst Group of New York Conference (CAGNY ) 2025 - 2025 targets 3–4% organic sales and 7–8% EPS growth, fueled by innovation and global expansion.CHD
Q4 2024 & Investor Day 2025